Current Updates on the Role of MicroRNA in the Diagnosis and Treatment of Neurodegenerative Diseases
CONCLUSION: This review provides new therapeutic approaches and novel biomarkers for the diagnosis and prognosis of NDDs by using miRNA.PMID:37861022 | DOI:10.2174/0115665232261931231006103234 (Source: Current Gene Therapy)
Source: Current Gene Therapy - October 20, 2023 Category: Genetics & Stem Cells Authors: Ammara Saleem Maira Javaid Muhammad Furqan Akhtar Ali Sharif Bushra Akhtar Muhammad Naveed Uzma Saleem Mirza Muhammad Faran Ashraf Baig Hafiz Muhammad Zubair Talha Bin Emran Mohammad Saleem Ghulam Md Ashraf Source Type: research
Current Updates on the Role of MicroRNA in the Diagnosis and Treatment of Neurodegenerative Diseases
CONCLUSION: This review provides new therapeutic approaches and novel biomarkers for the diagnosis and prognosis of NDDs by using miRNA.PMID:37861022 | DOI:10.2174/0115665232261931231006103234 (Source: Current Gene Therapy)
Source: Current Gene Therapy - October 20, 2023 Category: Genetics & Stem Cells Authors: Ammara Saleem Maira Javaid Muhammad Furqan Akhtar Ali Sharif Bushra Akhtar Muhammad Naveed Uzma Saleem Mirza Muhammad Faran Ashraf Baig Hafiz Muhammad Zubair Talha Bin Emran Mohammad Saleem Ghulam Md Ashraf Source Type: research
Current Updates on the Role of MicroRNA in the Diagnosis and Treatment of Neurodegenerative Diseases
CONCLUSION: This review provides new therapeutic approaches and novel biomarkers for the diagnosis and prognosis of NDDs by using miRNA.PMID:37861022 | DOI:10.2174/0115665232261931231006103234 (Source: Current Gene Therapy)
Source: Current Gene Therapy - October 20, 2023 Category: Genetics & Stem Cells Authors: Ammara Saleem Maira Javaid Muhammad Furqan Akhtar Ali Sharif Bushra Akhtar Muhammad Naveed Uzma Saleem Mirza Muhammad Faran Ashraf Baig Hafiz Muhammad Zubair Talha Bin Emran Mohammad Saleem Ghulam Md Ashraf Source Type: research
Current Updates on the Role of MicroRNA in the Diagnosis and Treatment of Neurodegenerative Diseases
CONCLUSION: This review provides new therapeutic approaches and novel biomarkers for the diagnosis and prognosis of NDDs by using miRNA.PMID:37861022 | DOI:10.2174/0115665232261931231006103234 (Source: Current Gene Therapy)
Source: Current Gene Therapy - October 20, 2023 Category: Genetics & Stem Cells Authors: Ammara Saleem Maira Javaid Muhammad Furqan Akhtar Ali Sharif Bushra Akhtar Muhammad Naveed Uzma Saleem Mirza Muhammad Faran Ashraf Baig Hafiz Muhammad Zubair Talha Bin Emran Mohammad Saleem Ghulam Md Ashraf Source Type: research
Current Updates on the Role of MicroRNA in the Diagnosis and Treatment of Neurodegenerative Diseases
CONCLUSION: This review provides new therapeutic approaches and novel biomarkers for the diagnosis and prognosis of NDDs by using miRNA.PMID:37861022 | DOI:10.2174/0115665232261931231006103234 (Source: Current Gene Therapy)
Source: Current Gene Therapy - October 20, 2023 Category: Genetics & Stem Cells Authors: Ammara Saleem Maira Javaid Muhammad Furqan Akhtar Ali Sharif Bushra Akhtar Muhammad Naveed Uzma Saleem Mirza Muhammad Faran Ashraf Baig Hafiz Muhammad Zubair Talha Bin Emran Mohammad Saleem Ghulam Md Ashraf Source Type: research
Exosome miR-30a-5p Regulates Glomerular Endothelial Cells' EndMT and Angiogenesis by Modulating Notch1/VEGF Signaling Pathway
CONCLUSION: This study provides evidence that exosome miR-30a-5p suppresses EndMT and abnormal angiogenesis of GECs by modulating the Notch1/VEGF signaling pathway. These findings suggest that exosome miR-30a-5p could be a potential therapeutic strategy for the treatment of DN.PMID:37767799 | DOI:10.2174/0115665232258527230919071328 (Source: Current Gene Therapy)
Source: Current Gene Therapy - September 28, 2023 Category: Genetics & Stem Cells Authors: Yaxian Ning Xiaochun Zhou Gouqin Wang Lili Zhang Jianqin Wang Source Type: research
A Retrospective Analysis of the Lauren Classification in the Choice of XELOX or SOX as an Adjuvant Chemotherapy for Gastric Cancer
CONCLUSION: The patients of non-intestinal type GC may benefit from the SOX regimen. Differences were counted without being statistically significant with intestinal-type GC in the SOX or XELOX groups.PMID:37767800 | DOI:10.2174/0115665232247694230921060213 (Source: Current Gene Therapy)
Source: Current Gene Therapy - September 28, 2023 Category: Genetics & Stem Cells Authors: Ke Wang Yuanyuan Yu Jian Zhao Qianhao Meng Chang Xu Jing Ren Yanqiao Zhang Yusheng Wang Guangyu Wang Source Type: research
Exosome miR-30a-5p Regulates Glomerular Endothelial Cells' EndMT and Angiogenesis by Modulating Notch1/VEGF Signaling Pathway
CONCLUSION: This study provides evidence that exosome miR-30a-5p suppresses EndMT and abnormal angiogenesis of GECs by modulating the Notch1/VEGF signaling pathway. These findings suggest that exosome miR-30a-5p could be a potential therapeutic strategy for the treatment of DN.PMID:37767799 | DOI:10.2174/0115665232258527230919071328 (Source: Current Gene Therapy)
Source: Current Gene Therapy - September 28, 2023 Category: Genetics & Stem Cells Authors: Yaxian Ning Xiaochun Zhou Gouqin Wang Lili Zhang Jianqin Wang Source Type: research
A Retrospective Analysis of the Lauren Classification in the Choice of XELOX or SOX as an Adjuvant Chemotherapy for Gastric Cancer
CONCLUSION: The patients of non-intestinal type GC may benefit from the SOX regimen. Differences were counted without being statistically significant with intestinal-type GC in the SOX or XELOX groups.PMID:37767800 | DOI:10.2174/0115665232247694230921060213 (Source: Current Gene Therapy)
Source: Current Gene Therapy - September 28, 2023 Category: Genetics & Stem Cells Authors: Ke Wang Yuanyuan Yu Jian Zhao Qianhao Meng Chang Xu Jing Ren Yanqiao Zhang Yusheng Wang Guangyu Wang Source Type: research
Exosome miR-30a-5p Regulates Glomerular Endothelial Cells' EndMT and Angiogenesis by Modulating Notch1/VEGF Signaling Pathway
CONCLUSION: This study provides evidence that exosome miR-30a-5p suppresses EndMT and abnormal angiogenesis of GECs by modulating the Notch1/VEGF signaling pathway. These findings suggest that exosome miR-30a-5p could be a potential therapeutic strategy for the treatment of DN.PMID:37767799 | DOI:10.2174/0115665232258527230919071328 (Source: Current Gene Therapy)
Source: Current Gene Therapy - September 28, 2023 Category: Genetics & Stem Cells Authors: Yaxian Ning Xiaochun Zhou Gouqin Wang Lili Zhang Jianqin Wang Source Type: research
A Retrospective Analysis of the Lauren Classification in the Choice of XELOX or SOX as an Adjuvant Chemotherapy for Gastric Cancer
CONCLUSION: The patients of non-intestinal type GC may benefit from the SOX regimen. Differences were counted without being statistically significant with intestinal-type GC in the SOX or XELOX groups.PMID:37767800 | DOI:10.2174/0115665232247694230921060213 (Source: Current Gene Therapy)
Source: Current Gene Therapy - September 28, 2023 Category: Genetics & Stem Cells Authors: Ke Wang Yuanyuan Yu Jian Zhao Qianhao Meng Chang Xu Jing Ren Yanqiao Zhang Yusheng Wang Guangyu Wang Source Type: research
Exosome miR-30a-5p Regulates Glomerular Endothelial Cells' EndMT and Angiogenesis by Modulating Notch1/VEGF Signaling Pathway
CONCLUSION: This study provides evidence that exosome miR-30a-5p suppresses EndMT and abnormal angiogenesis of GECs by modulating the Notch1/VEGF signaling pathway. These findings suggest that exosome miR-30a-5p could be a potential therapeutic strategy for the treatment of DN.PMID:37767799 | DOI:10.2174/0115665232258527230919071328 (Source: Current Gene Therapy)
Source: Current Gene Therapy - September 28, 2023 Category: Genetics & Stem Cells Authors: Yaxian Ning Xiaochun Zhou Gouqin Wang Lili Zhang Jianqin Wang Source Type: research
A Retrospective Analysis of the Lauren Classification in the Choice of XELOX or SOX as an Adjuvant Chemotherapy for Gastric Cancer
CONCLUSION: The patients of non-intestinal type GC may benefit from the SOX regimen. Differences were counted without being statistically significant with intestinal-type GC in the SOX or XELOX groups.PMID:37767800 | DOI:10.2174/0115665232247694230921060213 (Source: Current Gene Therapy)
Source: Current Gene Therapy - September 28, 2023 Category: Genetics & Stem Cells Authors: Ke Wang Yuanyuan Yu Jian Zhao Qianhao Meng Chang Xu Jing Ren Yanqiao Zhang Yusheng Wang Guangyu Wang Source Type: research
Exosome miR-30a-5p Regulates Glomerular Endothelial Cells' EndMT and Angiogenesis by Modulating Notch1/VEGF Signaling Pathway
CONCLUSION: This study provides evidence that exosome miR-30a-5p suppresses EndMT and abnormal angiogenesis of GECs by modulating the Notch1/VEGF signaling pathway. These findings suggest that exosome miR-30a-5p could be a potential therapeutic strategy for the treatment of DN.PMID:37767799 | DOI:10.2174/0115665232258527230919071328 (Source: Current Gene Therapy)
Source: Current Gene Therapy - September 28, 2023 Category: Genetics & Stem Cells Authors: Yaxian Ning Xiaochun Zhou Gouqin Wang Lili Zhang Jianqin Wang Source Type: research
A Retrospective Analysis of the Lauren Classification in the Choice of XELOX or SOX as an Adjuvant Chemotherapy for Gastric Cancer
CONCLUSION: The patients of non-intestinal type GC may benefit from the SOX regimen. Differences were counted without being statistically significant with intestinal-type GC in the SOX or XELOX groups.PMID:37767800 | DOI:10.2174/0115665232247694230921060213 (Source: Current Gene Therapy)
Source: Current Gene Therapy - September 28, 2023 Category: Genetics & Stem Cells Authors: Ke Wang Yuanyuan Yu Jian Zhao Qianhao Meng Chang Xu Jing Ren Yanqiao Zhang Yusheng Wang Guangyu Wang Source Type: research
